| Agaricus bisporus |
Tyrosinase |
Inhibition |
11.0 |
% |
10.1021/jm101266s |
| Bacillus anthracis |
Anthrax lethal factor |
Inhibition |
16.0 |
% |
10.1021/jm101266s |
| Homo sapiens |
A498 |
GI50 |
7144.96 |
nM |
None |
| Homo sapiens |
A549 |
GI50 |
91411.32 |
nM |
None |
| Homo sapiens |
Adenosine A1 receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Adenosine A2a receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Adenosine A3 receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Alpha-1a adrenergic receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Alpha-2a adrenergic receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Alpha-2b adrenergic receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Alpha-2c adrenergic receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Arachidonate 5-lipoxygenase |
Inhibition |
9.0 |
% |
10.1021/jm101266s |
| Homo sapiens |
Beta-1 adrenergic receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Beta-2 adrenergic receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Bile salt export pump |
IC50 |
1000000.0 |
nM |
10.1124/dmd.112.047068 |
| Homo sapiens |
Bradykinin B2 receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
CAKI-1 |
GI50 |
73282.45 |
nM |
None |
| Homo sapiens |
cAMP-dependent protein kinase (PKA) |
Inhibition |
14.0 |
% |
10.1021/jm0408767 |
| Homo sapiens |
Cannabinoid CB1 receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
CCRF-CEM |
GI50 |
40457.59 |
nM |
None |
| Homo sapiens |
Cholecystokinin A receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Cholecystokinin B receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
c-Jun N-terminal kinase 1 |
Inhibition |
0.0 |
% |
10.1021/jm0408767 |
| Homo sapiens |
c-Jun N-terminal kinase 1 |
Inhibition |
33.0 |
% |
10.1021/jm200349b |
| Homo sapiens |
c-Jun N-terminal kinase 2 |
Inhibition |
0.0 |
% |
10.1021/jm0408767 |
| Homo sapiens |
COLO 205 |
GI50 |
162181.01 |
nM |
None |
| Homo sapiens |
Cyclin-dependent kinase 1 |
IC50 |
200000.0 |
nM |
10.1021/jm960666x |
| Homo sapiens |
Cyclooxygenase-2 |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Cytochrome P450 3A4 |
IC50 |
10000.0 |
nM |
None |
| Homo sapiens |
Cytosolic purine 5'-nucleotidase |
Inhibition |
19.0 |
% |
10.1021/acs.jmedchem.5b01616 |
| Homo sapiens |
Delta opioid receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
DLD-1 |
GI50 |
135207.26 |
nM |
None |
| Homo sapiens |
DMS-114 |
GI50 |
84139.51 |
nM |
None |
| Homo sapiens |
DMS-273 |
GI50 |
81096.11 |
nM |
None |
| Homo sapiens |
DNA-(apurinic or apyrimidinic site) lyase |
Potency |
8.9 |
nM |
None |
| Homo sapiens |
Dopamine D1 receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Dopamine D2 receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Dopamine D3 receptor |
AC50 |
14000.1 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Dopamine transporter |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Dual specificity mitogen-activated protein kinase kinase 1 |
Inhibition |
9.0 |
% |
10.1021/jm0408767 |
| Homo sapiens |
EKVX |
GI50 |
80909.59 |
nM |
None |
| Homo sapiens |
Endothelin receptor ET-A |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Epidermal growth factor receptor erbB1 |
Inhibition |
11.0 |
% |
10.1021/jm200349b |
| Homo sapiens |
Estrogen receptor alpha |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Focal adhesion kinase 1 |
Inhibition |
5.0 |
% |
10.1021/jm200349b |
| Homo sapiens |
Gamma-aminobutyric acid receptor subunit alpha-1/alpha-2/beta-2/gamma-2 |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Ghrelin receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Glucocorticoid receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Glycogen synthase kinase-3 beta |
Inhibition |
0.0 |
% |
10.1021/jm0408767 |
| Homo sapiens |
Glycogen synthase kinase-3 beta |
Inhibition |
57.0 |
% |
10.1021/jm200349b |
| Homo sapiens |
GTP-binding nuclear protein Ran/Importin subunit beta-1/Snurportin-1 |
Potency |
56234.1 |
nM |
None |
| Homo sapiens |
HCC 2998 |
GI50 |
124738.35 |
nM |
None |
| Homo sapiens |
HCT-116 |
GI50 |
250034.54 |
nM |
None |
| Homo sapiens |
HCT-15 |
GI50 |
97949.0 |
nM |
None |
| Homo sapiens |
Heat shock protein HSP 90-beta |
IC50 |
4000000.0 |
nM |
10.1021/jm900357y |
| Homo sapiens |
HepG2 |
Potency |
35481.3 |
nM |
None |
| Homo sapiens |
HERG |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Histamine H1 receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Histamine H2 receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Histamine H3 receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Histone deacetylase 6 |
Inhibition |
-1.89 |
% |
10.6019/CHEMBL4808148 |
| Homo sapiens |
Histone deacetylase 6 |
Inhibition |
2.43 |
% |
10.6019/CHEMBL4808148 |
| Homo sapiens |
HL-60 |
GI50 |
36559.48 |
nM |
None |
| Homo sapiens |
HOP-18 |
GI50 |
108893.01 |
nM |
None |
| Homo sapiens |
HOP-62 |
GI50 |
58884.37 |
nM |
None |
| Homo sapiens |
HOP-92 |
GI50 |
146217.72 |
nM |
None |
| Homo sapiens |
HT-29 |
GI50 |
120503.59 |
nM |
None |
| Homo sapiens |
IGROV-1 |
GI50 |
250034.54 |
nM |
None |
| Homo sapiens |
Inhibitor of nuclear factor kappa B kinase beta subunit |
Inhibition |
22.0 |
% |
10.1021/jm200349b |
| Homo sapiens |
Insulin-like growth factor I receptor |
Inhibition |
44.0 |
% |
10.1021/jm200349b |
| Homo sapiens |
K562 |
GI50 |
247742.21 |
nM |
None |
| Homo sapiens |
Kappa opioid receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
KM12 |
GI50 |
152756.61 |
nM |
None |
| Homo sapiens |
KM-20L2 |
GI50 |
250034.54 |
nM |
None |
| Homo sapiens |
Leucine-rich repeat serine/threonine-protein kinase 2 |
IC50 |
15809.0 |
nM |
10.1021/acs.jmedchem.1c00720 |
| Homo sapiens |
Leucine-rich repeat serine/threonine-protein kinase 2 |
Ki |
6715.0 |
nM |
10.1021/acs.jmedchem.1c00720 |
| Homo sapiens |
LOX IMVI |
GI50 |
139958.73 |
nM |
None |
| Homo sapiens |
M19-MEL |
GI50 |
141253.75 |
nM |
None |
| Homo sapiens |
Malme-3M |
GI50 |
100925.29 |
nM |
None |
| Homo sapiens |
MAP kinase-activated protein kinase 2 |
Inhibition |
80.0 |
% |
10.1021/jm200349b |
| Homo sapiens |
MAP kinase ERK1 |
Inhibition |
3.0 |
% |
10.1021/jm0408767 |
| Homo sapiens |
MAP kinase ERK2 |
Inhibition |
17.0 |
% |
10.1021/jm0408767 |
| Homo sapiens |
MAP kinase p38 alpha |
Inhibition |
7.0 |
% |
10.1021/jm0408767 |
| Homo sapiens |
MAP kinase p38 alpha |
Inhibition |
24.0 |
% |
10.1021/jm200349b |
| Homo sapiens |
Matrix metalloproteinase-1 |
Inhibition |
17.0 |
% |
10.1021/jm101266s |
| Homo sapiens |
Matrix metalloproteinase-2 |
Inhibition |
-1.0 |
% |
10.1021/jm101266s |
| Homo sapiens |
Matrix metalloproteinase 3 |
Inhibition |
10.0 |
% |
10.1021/jm101266s |
| Homo sapiens |
Matrix metalloproteinase 8 |
Inhibition |
9.0 |
% |
10.1021/jm101266s |
| Homo sapiens |
Matrix metalloproteinase 9 |
Inhibition |
-3.0 |
% |
10.1021/jm101266s |
| Homo sapiens |
MCF7 |
GI50 |
21281.39 |
nM |
None |
| Homo sapiens |
Melanocortin receptor 3 |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Mitogen-activated protein kinase kinase kinase 5 |
Inhibition |
88.0 |
% |
10.1021/jm200349b |
| Homo sapiens |
MOLT-4 |
GI50 |
19319.68 |
nM |
None |
| Homo sapiens |
Monoamine oxidase A |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Motilin receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
MT4 |
IC50 |
12000.0 |
nM |
10.1016/s0960-894x(04)00205-7 |
| Homo sapiens |
Mu opioid receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Muscarinic acetylcholine receptor M1 |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Muscarinic acetylcholine receptor M2 |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Muscarinic acetylcholine receptor M3 |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
NCI/ADR-RES |
GI50 |
46238.1 |
nM |
None |
| Homo sapiens |
NCI-H226 |
GI50 |
111173.17 |
nM |
None |
| Homo sapiens |
NCI-H23 |
GI50 |
81470.43 |
nM |
None |
| Homo sapiens |
NCI-H322M |
GI50 |
116144.86 |
nM |
None |
| Homo sapiens |
NCI-H460 |
GI50 |
26977.39 |
nM |
None |
| Homo sapiens |
NCI-H522 |
GI50 |
50699.07 |
nM |
None |
| Homo sapiens |
Neuronal acetylcholine receptor protein alpha-4 subunit |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Neuropeptide Y receptor type 1 |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Norepinephrine transporter |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Nuclear factor erythroid 2-related factor 2 |
Potency |
29092.9 |
nM |
None |
| Homo sapiens |
OVCAR-3 |
GI50 |
130617.09 |
nM |
None |
| Homo sapiens |
OVCAR-4 |
GI50 |
126473.63 |
nM |
None |
| Homo sapiens |
OVCAR-5 |
GI50 |
250034.54 |
nM |
None |
| Homo sapiens |
OVCAR-8 |
GI50 |
105438.69 |
nM |
None |
| Homo sapiens |
Phosphodiesterase 3A |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Phosphodiesterase 4D |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
PI3-kinase p110-alpha subunit |
Inhibition |
45.0 |
% |
10.1021/jm200349b |
| Homo sapiens |
PI3-kinase p110-delta subunit |
Inhibition |
68.0 |
% |
10.1021/jm200349b |
| Homo sapiens |
PI3-kinase p110-gamma subunit |
Inhibition |
66.0 |
% |
10.1021/jm200349b |
| Homo sapiens |
Poly [ADP-ribose] polymerase 14 |
Inhibition |
nan |
% |
None |
| Homo sapiens |
Poly [ADP-ribose] polymerase 15 |
IC50 |
15000.0 |
nM |
None |
| Homo sapiens |
Poly [ADP-ribose] polymerase 15 |
pIC50 |
nan |
None |
None |
| Homo sapiens |
Pregnane X receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Prelamin-A/C |
Potency |
2511.9 |
nM |
None |
| Homo sapiens |
Progesterone receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Protein kinase C alpha |
Inhibition |
6.0 |
% |
10.1021/jm0408767 |
| Homo sapiens |
Pyruvate dehydrogenase kinase isoform 1 |
Inhibition |
77.0 |
% |
10.1021/jm200349b |
| Homo sapiens |
Receptor protein-tyrosine kinase erbB-2 |
Inhibition |
3.0 |
% |
10.1021/jm200349b |
| Homo sapiens |
Receptor protein-tyrosine kinase erbB-4 |
Inhibition |
9.0 |
% |
10.1021/jm200349b |
| Homo sapiens |
Rho-associated protein kinase 1 |
Inhibition |
28.0 |
% |
10.1021/jm0408767 |
| Homo sapiens |
Rho-associated protein kinase 1 |
Inhibition |
80.0 |
% |
10.1021/jm200349b |
| Homo sapiens |
RPMI-8226 |
GI50 |
167880.4 |
nM |
None |
| Homo sapiens |
RXF 393 |
GI50 |
30130.06 |
nM |
None |
| Homo sapiens |
Serine/threonine-protein kinase AKT |
Inhibition |
0.0 |
% |
10.1021/jm0408767 |
| Homo sapiens |
Serine/threonine-protein kinase AKT |
Inhibition |
20.0 |
% |
10.1021/jm200349b |
| Homo sapiens |
Serine/threonine-protein kinase AKT2 |
Inhibition |
7.0 |
% |
10.1021/jm200349b |
| Homo sapiens |
Serine/threonine-protein kinase Aurora-A |
Inhibition |
90.0 |
% |
10.1021/jm200349b |
| Homo sapiens |
Serine/threonine-protein kinase Aurora-B |
Inhibition |
99.0 |
% |
10.1021/jm200349b |
| Homo sapiens |
Serine/threonine-protein kinase B-raf |
Inhibition |
63.0 |
% |
10.1021/jm200349b |
| Homo sapiens |
Serine/threonine-protein kinase PAK 2 |
Inhibition |
36.0 |
% |
10.1021/jm200349b |
| Homo sapiens |
Serine/threonine-protein kinase PIM1 |
Inhibition |
20.0 |
% |
10.1021/jm200349b |
| Homo sapiens |
Serine/threonine-protein kinase RAF |
Inhibition |
14.0 |
% |
10.1021/jm0408767 |
| Homo sapiens |
Serine/threonine-protein kinase RIPK2 |
Inhibition |
11.0 |
% |
10.1021/jm200349b |
| Homo sapiens |
Serine/threonine-protein kinase Sgk1 |
Inhibition |
76.0 |
% |
10.1021/jm200349b |
| Homo sapiens |
Serotonin 1a (5-HT1a) receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Serotonin 2a (5-HT2a) receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Serotonin 2b (5-HT2b) receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Serotonin 2c (5-HT2c) receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Serotonin transporter |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
SF-268 |
GI50 |
128528.67 |
nM |
None |
| Homo sapiens |
SF-295 |
GI50 |
107894.67 |
nM |
None |
| Homo sapiens |
SF-539 |
GI50 |
49659.23 |
nM |
None |
| Homo sapiens |
SK-MEL-2 |
GI50 |
250034.54 |
nM |
None |
| Homo sapiens |
SK-MEL-28 |
GI50 |
243220.4 |
nM |
None |
| Homo sapiens |
SK-MEL-5 |
GI50 |
96605.09 |
nM |
None |
| Homo sapiens |
SK-OV-3 |
GI50 |
250034.54 |
nM |
None |
| Homo sapiens |
SN12C |
GI50 |
96161.23 |
nM |
None |
| Homo sapiens |
SN12K1 |
GI50 |
213304.49 |
nM |
None |
| Homo sapiens |
SNB-19 |
GI50 |
120781.38 |
nM |
None |
| Homo sapiens |
SNB-75 |
GI50 |
121059.81 |
nM |
None |
| Homo sapiens |
SNB-78 |
GI50 |
113762.73 |
nM |
None |
| Homo sapiens |
Solute carrier organic anion transporter family member 1B1 |
Inhibition |
90.14 |
% |
10.1124/mol.112.084152 |
| Homo sapiens |
Solute carrier organic anion transporter family member 1B3 |
Inhibition |
81.98 |
% |
10.1124/mol.112.084152 |
| Homo sapiens |
SW-620 |
GI50 |
230674.72 |
nM |
None |
| Homo sapiens |
TAR DNA-binding protein 43 |
Potency |
14125.4 |
nM |
None |
| Homo sapiens |
Thromboxane A2 receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Tumor susceptibility gene 101 protein |
Potency |
89125.1 |
nM |
None |
| Homo sapiens |
Type-1 angiotensin II receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Tyrosine-protein kinase FES |
Inhibition |
20.0 |
% |
10.1021/jm200349b |
| Homo sapiens |
Tyrosine-protein kinase ITK/TSK |
Inhibition |
87.0 |
% |
10.1021/jm200349b |
| Homo sapiens |
Tyrosine-protein kinase JAK3 |
Inhibition |
78.0 |
% |
10.1021/jm200349b |
| Homo sapiens |
Tyrosine-protein kinase LCK |
Inhibition |
19.0 |
% |
10.1021/jm0408767 |
| Homo sapiens |
Tyrosine-protein kinase SYK |
Inhibition |
56.0 |
% |
10.1021/jm200349b |
| Homo sapiens |
Tyrosyl-DNA phosphodiesterase 1 |
Potency |
32642.7 |
nM |
None |
| Homo sapiens |
U-251 |
GI50 |
107646.52 |
nM |
None |
| Homo sapiens |
UACC-257 |
GI50 |
199986.19 |
nM |
None |
| Homo sapiens |
UACC-62 |
GI50 |
48083.93 |
nM |
None |
| Homo sapiens |
UO-31 |
GI50 |
129419.58 |
nM |
None |
| Homo sapiens |
Vasopressin V1a receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Vasopressin V2 receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Xanthine dehydrogenase |
IC50 |
10890.0 |
nM |
10.1016/j.bmc.2007.03.010 |
| Homo sapiens |
Xanthine dehydrogenase |
Inhibition |
61.3 |
% |
10.1016/j.bmc.2007.03.010 |
| Homo sapiens |
XF498 |
GI50 |
9397.23 |
nM |
None |
| Mus musculus |
Nitric oxide synthase, inducible |
Inhibition |
6.0 |
% |
10.1021/jm101266s |
| Mus musculus |
P388 |
GI50 |
64863.44 |
nM |
None |
| Mus musculus |
P388/ADR |
GI50 |
79250.13 |
nM |
None |
| Rattus norvegicus |
Androgen Receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Rattus norvegicus |
Ca2+/calmodulin-dependent protein kinase II (CaM kinase II) |
Inhibition |
0.0 |
% |
10.1021/jm0408767 |
| Rattus norvegicus |
c-Jun N-terminal kinase 3 |
Inhibition |
10.0 |
% |
10.1021/jm0408767 |
| Rattus norvegicus |
Cyclooxygenase-1 |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Rattus norvegicus |
GABA receptor alpha-1 subunit |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Rattus norvegicus |
Glutamate (NMDA) receptor subunit zeta 1 |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Severe acute respiratory syndrome coronavirus 2 |
Replicase polyprotein 1ab |
Inhibition |
15.81 |
% |
10.6019/CHEMBL4495564 |
| Severe acute respiratory syndrome coronavirus 2 |
SARS-CoV-2 |
IC50 |
19952.62 |
nM |
10.6019/CHEMBL4651402 |
| Severe acute respiratory syndrome coronavirus 2 |
SARS-CoV-2 |
IC50 |
20000.0 |
nM |
10.6019/CHEMBL4651402 |
| Severe acute respiratory syndrome coronavirus 2 |
SARS-CoV-2 |
Inhibition |
-0.1 |
% |
10.6019/CHEMBL4495565 |
| Severe acute respiratory syndrome coronavirus 2 |
SARS-CoV-2 |
Inhibition |
27.9 |
% |
10.21203/rs.3.rs-23951/v1 |
| Streptomyces avidinii |
Streptavidin |
Activity |
nan |
None |
10.1016/j.bmcl.2012.09.088 |
| None |
Hepatotoxicity |
Hepatotoxicity |
nan |
None |
10.1021/tx900326k |
| None |
No relevant target |
Log S |
-2.18 |
None |
10.1016/s0960-894x(00)00172-4 |
| None |
Phospholipidosis |
Phospholipidosis |
nan |
None |
10.1080/15376510701857262 |
| None |
Unchecked |
Ac50 |
39.81 |
uM |
None |
| None |
Unchecked |
AC50 |
39810.7 |
nM |
None |
| None |
Unchecked |
Activity |
nan |
None |
10.1021/jm9006356 |
| None |
Unchecked |
IC50 |
100.0 |
ug.mL-1 |
10.1021/np50077a014 |
| None |
Unchecked |
IC50 |
8290.0 |
nM |
10.1021/jm9006356 |
| None |
Unchecked |
IC50 |
445000.0 |
nM |
10.1021/acs.jmedchem.7b01066 |
| None |
Unchecked |
IC50 |
12900000.0 |
nM |
10.1016/j.bmcl.2009.11.017 |
| None |
Unchecked |
IC50 |
15800000.0 |
nM |
10.1016/j.bmcl.2009.11.017 |
| None |
Unchecked |
Inhibition |
35.0 |
% |
10.1021/jm9006356 |
| None |
Unchecked |
Inhibition |
88.0 |
% |
10.1016/s0960-894x(98)00095-x |
| None |
Unchecked |
Inhibition |
89.0 |
% |
10.1016/s0960-894x(98)00095-x |
| None |
Unchecked |
Inhibition |
99.0 |
% |
10.1016/s0960-894x(98)00095-x |
| None |
Unchecked |
Inhibition |
nan |
% |
10.1021/jm9006356 |
| None |
Unchecked |
Kd |
90000000.0 |
nM |
10.1021/jm900728u |
| None |
Unchecked |
Ki |
29.2 |
nM |
10.1021/jm9006356 |
| None |
Unchecked |
Ki |
47.1 |
nM |
10.1021/jm9006356 |
| None |
Unchecked |
Ki |
280.0 |
nM |
10.1021/jm401530a |
| None |
Unchecked |
Ki |
7000.0 |
nM |
10.1016/j.ejmech.2018.06.038 |
| None |
Unchecked |
Ratio Ki |
1.6 |
None |
10.1021/jm9006356 |